Published 4 August 2021 This application seeks to permit 2²-fucosyllactose (2²-FL), produced by genetically modified Escherichia coli K-12, in infant formula products. Approval report Approval report - 6 May 2022(pdf 363 kb)(word 170 kb) Supporting document 1 - Safety assessment at approval (pdf 410 kb)(word 323 kb) Call for submissions Call for submissions - 6 December 2021(pdf 308 kb) (word 143 kb) Supporting document 1 - Safety assessment (pdf 408 kb) (word 322 kb) Submissions(zip 1.64 mb) Administrative Assessment - 3 August 2021 (pdf 94.8 kb)(word 67.8 kb) Executive Summary (pdf 51.2 kb) Application (pdf 467 kb) Applications published on our website may contain material owned by a third party. If you wish to re-use third party material, you may need to seek permission from the copyright owner.
